FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 79 filers reported holding FATE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,775,000 | -23.4% | 71,640 | +19.9% | 0.62% | +2.1% |
| Q1 2022 | $2,316,000 | +6.0% | 59,732 | +60.0% | 0.61% | +15.7% |
| Q4 2021 | $2,184,000 | -50.7% | 37,325 | -26.9% | 0.53% | -56.7% |
| Q2 2021 | $4,429,000 | +300.1% | 51,031 | +279.9% | 1.22% | +321.1% |
| Q1 2021 | $1,107,000 | -81.7% | 13,432 | -79.8% | 0.29% | -86.8% |
| Q4 2020 | $6,055,000 | +169.5% | 66,585 | +18.5% | 2.18% | +228.9% |
| Q3 2020 | $2,247,000 | +7.6% | 56,210 | -7.7% | 0.66% | +477.4% |
| Q2 2020 | $2,089,000 | +130.8% | 60,892 | +49.5% | 0.12% | -72.0% |
| Q1 2020 | $905,000 | -65.7% | 40,732 | -69.8% | 0.41% | -50.7% |
| Q4 2019 | $2,642,000 | +2.0% | 135,022 | -19.0% | 0.83% | -10.5% |
| Q3 2019 | $2,590,000 | -22.2% | 166,782 | -18.4% | 0.93% | -37.2% |
| Q3 2018 | $3,329,000 | +255.7% | 204,333 | +147.5% | 1.48% | +264.8% |
| Q2 2018 | $936,000 | -38.3% | 82,572 | -46.8% | 0.41% | -28.3% |
| Q1 2018 | $1,516,000 | -55.4% | 155,344 | -72.1% | 0.57% | -45.6% |
| Q4 2017 | $3,401,000 | +214.9% | 556,679 | +104.1% | 1.04% | +218.0% |
| Q3 2017 | $1,080,000 | – | 272,700 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |